Wai Y Z, Pee X K, Lai Y P, Alias R
Kuala Lumpur Hospital, Department of Ophthalmology, Kuala Lumpur, Malaysia.
Sarawak General Hospital, Department of Ophthalmology, Sarawak, Malaysia.
Med J Malaysia. 2023 Jan;78(1):74-78.
This study aims to compare the 2-year graft survival and outcomes of descemet stripping endothelial keratoplasty (DSEK) and penetrating keratoplasty (PK) for the treatment of bullous keratopathy (BK) among multiethnic Malaysia populations treated at a Tertiary Eye Centre in Kuala Lumpur, Malaysia.
This was a retrospective study of BK or Fuchs endothelial dystrophy (FED) patients who underwent DSEK or PK from 2015 to 2019 in Kuala Lumpur Hospital with a minimal post-operative follow-up of 2 years. Outcome measures included best-corrected visual acuity (BCVA), graft survival and complications. A total of 26 DSEK cases and 32 PK cases were included.
At 2 years, graft survival rates were quite similar in two groups (DSEK 80.8% vs PK 75%, p=0.765). The mean follow-up period was 35.2 months in DSEK and 31.4 months for PK (p=0.465). The cumulative survival rates were slightly higher in the DSEK group (DSEK 73.1% vs PK 53.1%, p=0.119), but the result was not statistically significant. Postoperative complications were associated with higher graft failure in both groups (p=0.019). DSEK group has better post-operative BCVA (LogMAR DSEK 0.42 vs PK 0.83, p=0.003).
Similar graft survival rates were observed with both corneal transplant techniques for 2 years among Malaysian patients with BK. Post-operative complications can cause a higher risk of graft failure. DSEK produced better post-operative BCVA compared to PK.
本研究旨在比较在马来西亚吉隆坡一家三级眼科中心接受治疗的多民族人群中,用于治疗大泡性角膜病变(BK)的深板层内皮角膜移植术(DSEK)和穿透性角膜移植术(PK)的2年移植存活率及治疗效果。
这是一项对2015年至2019年在吉隆坡医院接受DSEK或PK手术的BK或Fuchs内皮营养不良(FED)患者的回顾性研究,术后最少随访2年。观察指标包括最佳矫正视力(BCVA)、移植存活率及并发症。共纳入26例DSEK病例和32例PK病例。
2年时,两组的移植存活率相当(DSEK为80.8%,PK为75%,p = 0.765)。DSEK组的平均随访期为35.2个月,PK组为31.4个月(p = 0.465)。DSEK组的累积存活率略高(DSEK为73.1%,PK为53.1%,p = 0.119),但结果无统计学意义。两组的术后并发症均与较高的移植失败率相关(p = 0.019)。DSEK组术后BCVA更好(DSEK的LogMAR为0.42,PK为0.83,p = 0.003)。
在马来西亚BK患者中,两种角膜移植技术在2年时观察到相似的移植存活率。术后并发症可导致较高的移植失败风险。与PK相比,DSEK术后BCVA更佳。